1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors-Reference-Cited by-同舟云学术

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

Published:2010-02-19 Issue:6 Volume:53 Page:2534-2551
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Micheli Fabrizio¹,Cavanni Paolo¹,Arban Roberto¹,Benedetti Roberto¹,Bertani Barbara¹,Bettati Michela¹,Bettelini Letizia¹,Bonanomi Giorgio¹,Braggio Simone¹,Checchia Anna¹,Davalli Silvia²,Di Fabio Romano¹,Fazzolari Elettra¹,Fontana Stefano¹,Marchioro Carla²,Minick Doug²³,Negri Michele¹,Oliosi Beatrice²,Read Kevin D.⁴,Sartori Ilaria¹,Tedesco Giovanna²,Tarsi Luca¹,Terreni Silvia¹,Visentini Filippo²,Zocchi Alessandro¹,Zonzini Laura¹

Affiliation:

1. Neurosciences Centre of Excellence for Drug Discovery

2. Molecular Discovery Research

3. Molecular Discovery Research, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina

4. Biological Chemistry and Drug Discovery, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee DD1 5EH, Scotland, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm901818u

Reference28 articles.